Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07475832
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 45 years and older
* Previously underwent complex cataract removal by phacoemulsification with a clear corneal incision in one or both eyes more than 1 month before enrollment
* Complex cataract removal was performed for poor red reflex or poor visualization due to lens density or opacification
* Pre-operative dense cataract in the study eye, defined as greater than or equal to 3+ posterior subcapsular cataract, 3+ nuclear sclerotic cataract, 3+ cortical cataract, or any combination of these
* Pre-operative biometry performed with both the ARGOS and IOLMaster 700
* Other than cataract, clear intraocular media, with no corneal opacity or vitreous hemorrhage
Exclusion Criteria:
* Pre-operative mature or white cataract in the study eye
* Any corneal abnormality, other than regular corneal astigmatism, that in the opinion of the investigator would confound study outcomes
* History of or current retinal condition, or predisposition to retinal conditions, other than posterior vitreous detachment, that in the opinion of the investigator would confound study results
* Amblyopia or strabismus in either eye
* Nystagmus or other condition that would hamper axial length capture because of poor fixation
* History of or current anterior or posterior segment inflammation of any etiology
* Any form of ocular neovascularization
* Diagnosed degenerative eye disorders
* Acute or chronic disease or illness that, in the opinion of the investigator, would confound study results, including immunocompromised state, connective tissue disease, or clinically significant atopic disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT07475832
Study Brief:
Protocol Section:
NCT07475832